A potential role for Nox1-centered NADPH oxidase in gastric inflammation has been proposed [9], and there is evidence that inflammatory bowel disease is associated with increased expression of NoxO1, induced by TNFα/NFκB, resulting in higher levels of ROS formation derived from the Nox1-centered NADPH oxidase [10]. The gene discussed is FMO5; the disease is inflammatory bowel disease.